dimyristoylphosphatidylglycerol has been researched along with Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahiwale, R; Bothiraja, C; Mahadik, K; Pawar, A; Poudel, I | 1 |
| Alipour, M; Heney, M; Mugabe, C; Omri, A; Suntres, Z; Th'ng, J; Vergidis, D | 1 |
| Casale, F; Cilurzo, F; Cosco, D; Fresta, M; Paolino, D | 1 |
3 other study(ies) available for dimyristoylphosphatidylglycerol and Breast Cancer
| Article | Year |
|---|---|
Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
Topics: Animals; Antineoplastic Agents; Biotin; Breast Neoplasms; Chelating Agents; Chitosan; Delayed-Action Preparations; Docetaxel; Drug Carriers; Drug Design; Humans; MCF-7 Cells; Molecular Targeted Therapy; Nanostructures; Phosphatidylglycerols; Rats; Tissue Distribution | 2018 |
Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Chemistry, Pharmaceutical; Dimyristoylphosphatidylcholine; Drug Delivery Systems; Female; Humans; Liposomes; Paclitaxel; Particle Size; Phosphatidylglycerols; Solubility | 2010 |
Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cholesterol; Colloids; Deoxycytidine; Dose-Response Relationship, Drug; Drug Compounding; Fatty Acids, Monounsaturated; Female; Gemcitabine; Humans; Kinetics; Lipids; Liposomes; Particle Size; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Quaternary Ammonium Compounds; Selective Estrogen Receptor Modulators; Solubility; Tamoxifen; Technology, Pharmaceutical | 2012 |